24-week post-therapy factors | Univariate analyses | Multivariate analyses | ||
---|---|---|---|---|
 | 95% CI of β (β) | p values | 95% CI of β (β) | p values |
Male, yes | − 1.708 to − 0.548(− 1.128) |  < 0.001 | − 1.89 to − 0.5 (− 1.195) | 0.001 |
Age, (years) | − 0.01 to 0.037 (0.013) | 0.252 |  |  |
BMI (kg/m2) | − 0.183 to 0.136 (− 0.11) | 0.004 | − 0.139 to 0.16 (− 0.039) | 0.443 |
ALT (U/L) | − 0.042 to − 0.003 (− 0.023) | 0.024 | − 0.04 to 0.004 (− 0.018) | 0.112 |
eGFR (mL/min/1.73 m2) | − 0.024 to − 0.005 (− 0.015) | 0.002 | − 0.02 to − 0.001(− 0.011) | 0.034 |
TG (mg/dL) | − 0.008 to − 0.001 (− 0.005) | 0.007 | − 0.005 to 0.002 (− 0.002) | 0.385 |
TC (mg/dL) | − 0.005 to 0.011 (0.003) | 0.418 |  |  |
HOMA-IR | − 0.153 to 0.045 (− 0.054) | 0.283 |  |  |
Uric acid (mg/dL) | − 0.326 to 0.047 (− 0.14) | 0.141 |  |  |
NLR | − 0.216 to 0.334 (0.059) | 0.673 |  |  |
Platelet (103/uL) | − 0.01 to 0.00 (− 0.005) | 0.039 |  |  |
Liver cirrhosis, yes | − 0.91 to 0.484 (− 0.213) | 0.548 |  |  |
Fibrosis-4 score | 0.026 to 0.265 (0.146) | 0.017 | − 0.044 to 0.197 (21.72) | 0.077 |
Ferritin (ng/mL) | − 0.001 to 0.001 (0.000) | 0.904 |  |  |
IFNL3-rs12979860 CC genotype, yes | − 0.502 to 1.038 (0.268) | 0.494 |  |  |